T2D and the heart

Listen to the episode

Description

In this episode:

  • In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits
  • The incidence of heart failure, silent ischaemia and arrhythmias are higher in patients with T2DM and GPs need a high index of suspicion to identify, diagnose and treat these

 

Host: Dr David Lim, GP and Medical Educator

Total time: 27 mins

Guest: A/Prof Neale Cohen, Endocrinologist

 

Last Updated: 19 Aug, 2021

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Sonia Grover

Prof Sonia Grover

Paediatric Gynae Vulval Problems

A/Prof Samantha Hocking

A/Prof Samantha Hocking

Practical Guide to Tirzepatide

Prof Adrian Esterman

Prof Adrian Esterman

COVID Update

Prof Frank Vajda AM

Prof Frank Vajda AM

Pregnancy and Epilepsy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Neale Cohen

expert

A/Prof Neale Cohen

Endocrinologist; Director of Clinical Diabetes, the Baker Heart and Diabetes Institute, Melbourne

Recent articles

Share this

You have completed the Educational Activities component of this resource. 

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.